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1. Introduction 
Autoimmune diseases may have an adverse effect on reproduction and pregnancy 
outcome. Systemic Lupus Erythematosus (SLE) is associated with a wide variety of 
antibodies to different cell body components, mostly antiphospholipid antibodies. These 
are a heterogeneous group of antibodies that bind to negatively charged phospholipids 
and/or serum phospholipid binding proteins. Antiphospholipid syndrome (APLs) may 
occur as primary APLs or in association with autoimmune diseases. During normal 
pregnancy maternal immunity and hormones allow fetal survival, but when these 
mechanisms are impaired it may have a detrimental effect on the fetus. Pregnancies in 
women with APLs can be complicated by a high rate of pregnancy loss, pre-eclampsia, 
fetal growth restriction, prematurity and fetal distress. Disease flare during pregnancy 
predicts adverse fetal outcome (Kwok et al., 2011). The mechanisms underlying the 
recurrent abortions and fetal loss among women suffering from SLE are not completely 
elucidated. Thrombotic placental events may explain only some of the miscarriages. In 
vitro cell culture of placental trophoblast cell lines with IgG from patients suffering from 
APLs showed that APLs/ anti-β2-glycoprotein I antibodies / anti-β 2 globulin antibodies 
might disrupt the annexin coverage of thrombogenic anionic surfaces on the trophoblast 
and endothelial cell monolayers and lead to Factor X and prothrombin activation (Rand et 
al., 1997). However histopathological findings suggestive of thrombosis cannot be 
detected in the majority of the placentas from women suffering from APLs (Levy et al., 
1998, Meroni et al., 2008). It has been suggested that antiphosholipids may be responsible 
for a local acute inflammatory response mediated by complement activation and 
neutrophil infiltration that eventually leads to fetal loss. Circulating antiphospholipid 
antibodies occurring at about 40% of SLE patients are associated with fetal loss. Some 
investigators regard APLs as a marker for recurrent abortions and not necessarily as their 
primary cause. Lupus anticoagulants, anticardiolipin and anti-β2-glycoprotein I 
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antibodies are typically found among the patients. Complement activation was shown to 
play a role in antiphospholipid antibody - mediated fetal loss associated with 
inflammatory process, when C4d, a degradation product of C4 was demonstrated in 
human placenta of SLE patients (Cohen et al., 2011), as well as diminished number of T 
regulatory cells, associated with pregnancy loss and pre-eclampsia (Tower et al., 2011). 
Circulating microparticles that expose phospholipids in the outer membrane and induce 
coagulation via tissue factor have been associated with lupus anticoagulants and poor 
obstetric outcome (Alijotas-Reig et al., 2009). Other reports indicate that enhanced 
oxidative stress could be linked to autoimmune diseases; however, there is lack of data 
about anti oxidant status of the placenta and embryos during pregnancy in women 
suffering from autoimmune diseases. 
2. The role of experimental animal studies in evaluation of pregnancy 
complications among women suffering from autoimmune diseases 
As more than one mechanism of pathogenesis exists for fetal damage in autoimmune 
diseases, experimental animal models can be used to isolate the different causative effects. 
Evaluation of the role of different antibodies and molecules can be obtained by direct 
injection or induction of antibodies production in the pregnant animals and evaluation of 
the resultant effect on the embryos and fetuses. In such case the effect is evaluated in normal 
animals rather than being secondary to an autoimmune disease.  
Previous published studies revealed fetal damage induced by various antibodies. A smaller 
litter size was demonstrated after the injection to pregnant BALB/C mice with a human 
cytomegalovirus -peptide-induced monoclonal antiphospholipid (Gharavi et al., 2004). Fetal 
heart block and bradycardia were evidenced in a murine model as a result of maternal 
autoantibodies to Ro and La antigen induced by maternal immunization (Suzuki et al., 
2005). In addition maternal immunization with DNA memitope in mice led to the induction 
of autoantibodies that bind DNA and the N-methyl-D-aspartate receptor in the maternal 
circulation leading to increased neocortical cell death in the fetal brain and subsequent 
delayed acquisition of neonatal reflexes and cognitive impairments in the adult offspring. In 
this model the antibodies that were detected in the fetal neocortex outside of blood vessels 
evidenced their transport through fetal circulation until binding to the fetal brain (Lee et al., 
2009). We previously found that the immunization of BALB /C mice with mouse laminin-1 
was followed by the development of anti-laminin-1 antibodies. A double fetal resorption 
rate and lower fetal and placental weight was found in the laminin-1 immunized group 
compared with controls. Resorption rate was highest in the subgroup of animals with very 
high levels of anti-laminin-1 (Matalon et al., 2003). Other molecules were also found to have 
direct embryotoxic effects. The injection of a low-molecular weight fraction of boiled human 
serum containing antiphospholipid antibodies that had been obtained from women with 
antiphospholipid syndrome to pregnant rats at day 5 - 6 of pregnancy resulted in increased 
embryonic apoptosis 2 to 4 hours after the injection  (Halperin et al., 2008). 
3. In vitro systems to evaluate sera toxicity in autoimmune diseases 
To try to evaluate the different mechanisms that lead to poor obstetric outcome we practiced 
three in vitro systems that use sera obtained from patients suffering from autoimmune 
diseases and recurrent abortions as culture media. 
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3.1 In vitro development of pre-implantation mice embryos in culture 
Mouse blastocysts obtained from the uterine horns before implantation at 3.5 days of 
gestation can be cultured for up to 10 days and reach the developmental stage equivalent of 
9.5 to 10 days of gestation in utero, or one-half of the total gestational period. At that early 
somite stage, the blood circulation in the yolk sac is not yet established and the anterior 
neuropore is open. The limb buds and the primordia of the lung, liver, and pancreas are not 
yet present (Chen & Hsu, 1982). 
The technology in brief: Female mice are treated with gonadotropins followed 48 h later 
by Human Chorionic Gonadotropin in order to cause super-ovulation. The mice are 
mated with males and insemination is verified the following morning by the finding of a 
copulation plug in the vagina (day 0). Late morula-early blastocyst stages are obtained by 
flushing the uterine horns with culture medium 3 days after mating. Embryos are 
removed from several mice, pooled in an embryological watchglass, washed and 
transferred to fresh medium. A group of 8-10 embryos are placed in drops with Eagle's 
medium supplemented with 50% or 80% human serum. L Glutamine is added to the 
medium in a concentration of 2 mM/cc. Embryos are cultured in a humidified 
atmosphere in unaerobic conditions under paraffin drops. They are checked before 
incubation, after 24 and 72 hours or other incubation times under an inverted microscope 
to determine the developmental stage. The parameters used as criteria for assessing the 
rate of development and differentiation of embryos are namely, hatching of blastocysts 
from the zona pellucida, their adhesion to the substratum, and outgrowth and spreading 
on the surface (Abir et al., 1990). 
Using this method, one can examine direct effects of the sera from women with recurrent 
abortions on early pre-implantation embryos. 
3.2 In vitro development of early somite stage rat embryos in culture 
The early somite rat embryo culture allows the investigation of the embryotoxicity of 
various teratogens in face of the difficulty to perform studies on mammalian embryos while 
in utero (New et al., 1976). It is an in vitro method to evaluate teratogenicity of various 
chemicals (i.e. different drugs and chemicals) as the tested compounds are added to the 
culture medium and the embryos cultured during organogenesis (New et al., 1976). The 
various agents can be evaluated either individually or in combination. Adverse embryonic 
outcomes (malformations or embryolethality) were shown to be directly related to the 
serum concentration of the compound being tested and can be compared to the serum 
concentration in the human. Moreover, as embryos can also be cultured directly on human 
serum, it may serve as a tool to investigate the direct effects of sera from women with 
different diseases on embryonic development. Additionally, the early somite rat embryo 
culture model can allow the evaluation of success of various treatment modalities and thus 
may be an important tool to predict the outcome of the pregnancy. This can be achieved due 
to the yolk sac (the chorioallantoic placental equivalent at this stage in rat pregnancy) which 
provides a large surface area for nutritional and respiratory exchange between the embryo 
and the culture medium. Previous studies proved that rat conceptuses explanted at 9.5-12.5 
days, when the embryo develops from the early neurula to the late tail bud stage, can be 
maintained in vitro for 48 hours with almost 100% survival and growth that is 
indistinguishable from that occurring in vivo.  
The technology in brief: Pregnant female rats are euthanized on day 9.5 to 12.5 of pregnancy 
when sperm finding is considered to be day 0. The embryos are cultured for 28-48 hours at 
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37°C in rotating bottles, and supplemented with gas mixtures: day-1: 20% Oxygen, 75% N2, 
5% CO2, and day-2: 40% oxygen, 55% N2, and 5% CO2. After 28-48 hours of culture the 
embryos are examined under a dissecting microscope and scored according to the method 
described by Brown et al (Brown & Fabro, 1981) and us (Abir & Ornoy, 1996, Abir et al., 1994). 
Only embryos with a beating heart are examined for yolk sac size and circulation, axial 
rotation, neural tube closure, presence of telencephalic vesicles, optic and otic vesicles, number 
of somites, body size, and presence of gross anomalies. The use of morphological scoring 
system provides an index for embryonic development proportional to the embryonic age and 
aids in the detection of anomalies induced by the different teratogens. The embryos and yolk 
sacs are kept for different morphological, biochemical and molecular studies.  
The possible direct effects of the sera from women with autoimmune diseases can be 
examined on cultured rat embryos using sera or IgG obtained from women with SLE/APLs 
as the culture medium, and analyzing the effects these sera has on embryonic growth, rate 
of anomalies, and ultrastructural yolk sac damage compared to sera from control healthy 
women and control rats. 
3.3 Human placental explants in culture 
The use of first trimester chorionic villi explants cultures has the advantage over cell culture 
of being the in vivo source of extravillous trophoblast and the preservation of topological 
and functional villous-extravillous trophoblast inter-relationships. It was demonstrated that 
first trimester villous explants maintained on Matrigel or rat tail collagen support the villous 
explants differentiation, migration and hormone production in 98 per cent of cultures 
(Genbacev et al., 1992). The study of placental explants in culture, where no blood 
circulation exists, enabled the evaluation of the direct effects of different sera on the 
placenta, thus exposing the mechanisms of placental damage other than placental infarcts, 
thrombosis and vasculopathy. 
The technique in brief: Placental tissue of 5.5–7.5 weeks of gestation are transferred on sterile 
gauze in an ice-cold phosphate-buffered saline and then removed to a Petri dish and rinsed 
in phosphate buffered saline. Placental tissue is dissected from deciduas and fetal 
membranes for inspection under a dissecting microscope. Explants of approximately 10 mg 
wet weight are transferred into Millicell-CM culture dish insert (Millipore, Bedford, MA), 
which has been previously layered with polymerized Matrigel® (Collaborative Research, 
Bedford, MA). The inserts are then placed in 24-well culture dishes. Explants are placed in 
incubator (5% CO2) for 60 min at 39°C to evaporate phosphate buffered saline droplets to 
assist in villi adherence to the thin layer of Matrigel®. Cultures are incubated overnight in 
an incubator with 5% CO2. Twelve hours from the initiation of culture 400 µl of different 
types of different sera enriched with 1 mg glucose/ml are added directly to the inserts. Both 
the media from the insert (top) and the well (bottom) are changed every 48 hr, collected, and 
stored at -20°C until assayed. Villous explants are inspected daily using an inverted phase-
contrast microscope for general cellular integrity, cellular proliferation, and outgrowth. The 
explants remain in culture for 4 days. At the end of the experiment, villi with supporting 
Matrigel® are dissected out using surgical blades and kept for morphological, 
immunohistochemical biochemical and molecular studies, and the media is removed for the 
analysis of major hormones secreted by the placental tissue. 
To evaluate the possibility that in SLE/APLs at least some of the antibodies may directly 
damage placental trophoblastic cells, consequently causing fetal damage that may lead to 
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intrauterine growth restriction or fetal death and to evaluate therapeutic interventions we 
used human placental explants in culture. 
4. In vitro studies of embryotoxicity of sera from women with recurrent 
abortions on pre-implantation mice in culture 
4.1 The embryotoxicity of sera from women with recurrent abortions on pre-
implantation mice in culture 
Mouse blastocysts 3.5-day-old at late morula stage and inside the zona pellucida,  
were cultured for 72 h in 50% or 80% sera from women with recurrent abortions. In 
embryos cultured in sera from women with recurrent abortions, 53.2% did not reach 
blastocystic development, compared to 33.6% of the embryos grown on sera from women 
after only one miscarriage and 8.2% and 12% on control sera from women following 
delivery of a normal infant or on sera obtained from women in the second trimester of a 
normal pregnancy respectively. When sera from women with miscarriages were divided 
into “high risk'”(50% or more embryotoxicity) and “low risk”(less than 50% 
embryotoxicity) sera, the “high risk” sera from two or more miscarriages caused an 
average of 72.1% undevelopment (i.e. not reaching the blastocystic stage), while the  
“low risk” sera from the same group caused 33.6% undevelopment. The “high risk” sera 
from one miscarriage were embryotoxic to 55.8% of the blastocysts and the “low risk” sera 
from the same group caused only 8.7% undevelopment similar to the controls (Abir et  
al., 1990).  
4.2 The limitations of the pre-implantation rat culture 
The limitations of this method is that it is impossible to evaluate even early post-
implantation periods that equivalents early organogenesis. It cannot be used for the study of 
growth restriction and for the effects of teratogens which affect the embryo in later stage. In 
addition, the small embryonic size limits the possibility to perform various biochemical and 
genetic studies and does not allow the investigation of the effect of the different chemicals 
on isolated organs. 
In conclusion: More pre-implantation mouse blastocytes failed to reach blastocystic 
development when cultured in sera obtained from women with recurrent abortions 
compared to those cultured in control sera.  
5. In vitro studies of the embryotoxicity of sera from patients suffering from 
systemic lupus erythematosus/antiphospholipid syndrome on early somite 
rat embryos in culture 
5.1 The role of IgG antibodies in recurrent abortions 
To test the hypothesis that IgG antibodies from women with recurrent abortions may be 
responsible for the miscarriage, sera from women one day after an abortion were used as 
culture media for 10.5 days old embryos and compared to human control sera obtained from 
women either during a second trimester of a normal pregnancy or a day after normal 
delivery. Anomalies rate increased from 22% among controls to 47% among embryos 
cultured in sera from women who had a history of one abortion and to 54% among embryos 
cultured in sera from women who had a history of two abortions or more. Anomalies 
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included mainly microcephaly, open neural tube, lack of eyes and cardiac anomalies. The 
difference between the sera was more prominent when the sera were classified as low- less 
than 50% anomalies compared to high-more than 50%. The high rate of anomalies was 
particularly characteristic to the highly teratogenic sera while in the other sera anomalies 
rate was similar to controls. This difference may indicate a basic difference between the two 
sera groups: one that has a factor(s) that is teratogenic in this model and the other that 
induces abortions in a different mechanism that is not relevant to this model.  
 
 
Fig. 1. Early somite 10.5 days rat embryo after 28 hours in culture: normal embryo 
To further evaluate whether the embryotoxic factor in this model is IgG, we used high risk 
sera and control sera, separated the IgG fraction and exchanged it between the sera. We 
defined three groups: one in which IgG from controls corrected the anomalies induced by 
the toxic sera, and the IgG from toxic sera induced anomalies in the embryos cultured in 
the control sera, the second in which control sera did not reduce the rate of anomalies but 
the IgG induced anomalies in the controls, and the third in which no effect was 
demonstrated after IgG exchange. We assumed that in these embryos a different factor 
was responsible for the teratogenicity. When the yolk sacs were evaluated by transmission 
electron microscopy we found a morphological damage represented by fewer microvilli 
and more inclusions in the entodermal epithelial cell in the sacs from embryos cultured in 
high risk sera (Abir et al., 1993).  
5.2 The role of IgG antibodies in intra-uterine growth restriction 
Besides recurrent abortions and fetal death, a main morbidity among infants of mothers 
suffering from autoimmune diseases is intra-uterine growth restriction. To investigate the 
role of the IgG antibodies on embryonic and fetal growth we evaluated the effect of high 
levels of antiphospholipid and anti DNA antibodies on 11.5 days rat embryos in culture, a 
stage when most of the organs have already been formed. Reduced fetal growth and yolk  
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Fig. 2. Early somite 10.5 days rat embryo after 28 hours in culture: arrow-open neural tube  
sac diameter were found in embryos cultured in media containing IgG from women 
suffering from SLE / recurrent abortions, compared to IgG from controls or medium 
without IgG. When we evaluated the role of the different IgG fractions (anticardiolipin-β2 
glycoprotein, antiphosphatidylserine, anti-double stranded DNA, anti-laminin, anti-
thyroglobulin and anti-pyruvate dehydrogenase) compared to controls, only embryos that 
were cultured in sera positive for anti-cardiolipin were significantly smaller than the 
embryos cultured in sera containing normal IgG fractions. The embryos cultured in medium 
containing anticardiolipin/ anti DNA/ antiphosphatidylserine had a smaller yolk sac. 
However, embryos cultured in sera from SLE patients with a history of recurrent abortions 
were also smaller even when they were negative for antiphosphatydilserine. In spite of the 
fact that in these experiments the embryos were cultured towards the end of organogenesis 
when many of the organs have already been formed, 15.6% of the embryos exposed to IgG 
purified from women suffering from SLE / recurrent abortions had anomalies, while only 
8.7% of the embryos exposed to IgG purified from sera of healthy women were malformed. 
There was a significant difference in the development of the brain and branchial bars 
between embryos that were exposed to patients’ IgG and those exposed to IgG that was 
purified from healthy women. There was also a significant reduced somite number among 
the experimental group embryos (Matalon et al., 2002). 
5.3 The effect of IgG antibodies on the yolk sac 
The embryos at the early somite stage are surrounded by their yolk sac and by their 
ectoplacental cone which is the trophoblastic part of the cellular complex at the embryonic 
pole of the blastocyst. The ectoplacental cone is responsible for the invasion into the 
decidua. To evaluate the mechanism by which IgG affects the yolk sac, 11.5 days old 
embryos were cultured in two human IgG2 monoclonal antiphosphatidylserine antibodies 
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(HL5B, RR7F). The antiphosphatidylserine antibodies were associated with implantation 
failure in previous studies with mainly trophoblastic injury by inhibition of syncytium 
formation, decreased human chorionic gonadatropin (hCG) production, and disturbed 
trophoblast invasion (McIntyre, 2003). The HL5B monoclonal antibody was generated from 
a primary antiphospholipid syndrome patient with multiple central ischemic events and the 
RR7F monoclonal antibody was generated from SLE patient with high titers of circulating 
antiphosphatidylserine and anticardiolipin antibodies, with no history of thrombosis or fetal 
loss. Both antibodies showed reactivity against phosphatidylserine and cross-reactivity with 
cardiolipin but lacked reactivity against β2-glycoprotein and did not have a lupus 
anticoagulant activity. Embryos cultured in both sera had reduced yolk sac diameter 
without significant difference in the rate of anomalies. Apoptotic processes were found in 
some of the giant cells and in most of the cells located in the area between the mature giant 
cells to the small cytotrophoblastic mononuclear cells. More apoptotic cells were counted 
within the ectoplacental giant cells exposed to anti phosphatidylserine in comparison with 
cells that were exposed to the control human IgG. More than 19% of the giant cells that were 
exposed to HL5B (from the patient with multiple ischemic events) underwent apoptosis, 
while only 12.7%of the cells exposed to RR7F (from the patient with high titers of circulating 
antiphosphatidylserine and anticardiolipin, with no thrombosis neither fetal loss) and 7.3 
and 9.6% of the cells exposed to the control IgG or the experimental medium alone 
underwent apoptosis. Both antibodies stained the ectoplacental cone in the rat embryos 
most strongly with the moderately larger cell layer. Cytotrophoblastic mononuclear cells, 
which are located in the center of the ectoplacental cone, were not stained. The control 
antibodies did not stain the ectoplacental cone at all. Immunofluorescence staining proved 
that the anti phosphatidylserine monoclonal antibodies, reacted with 11.5-day ectoplacental 
cone cells (Matalon et al., 2004). 
5.4 The embryotoxicity of oxidative stress 
The role of oxidative damage in disease activity among patients suffering from autoimmune 
diseases has become more evident in the last decade (Wang et al., 2010). Reactive Oxygen 
Species (ROS) have been implicated in causing immunogenic modifications in the DNA and 
causing oxidative damage that may lead to various autoimmune and degenerative diseases. 
Excessive ROS production which disturbs redox status, may damage macromolecules and 
modulate the expression of a variety of immune and inflammatory molecules leading to 
inflammatory processes and affecting tissue damage (Nathan, 2002).  
The role of oxidative stress in SLE was demonstrated in various studies including: an 
association of the oxidative stress parameters with the pro-inflammatory cytokines (Shah et 
al., 2011b); exposure of purified human dsDNA resulting in ROS production that led to 
changes in the primary structure of the dsDNA that rendered it highly immunogenic when 
injected into rabbits (Al Arfaj et al., 2007); a positive correlation between apoptotic cell 
numbers and ROS production and increased numbers of apoptotic cells positively 
correlating with lipid peroxidation in SLE patients (Shah et al., 2011a). The Conflicting 
results on antioxidant enzyme activities may be due to continued oxidative stress and 
measurement of different components of the antioxidant system at different disease stages 
(Ames et al., 1999, Whitaker & Knight, 2008, Zaken et al., 2000). However the role of 
oxidative stress in recurrent fetal death and growth restriction is unclear.  
Despite medical treatment, women with autoimmune diseases suffer from increased rate of 
pregnancy complication. We tried to determine if during remission there is a relation between 
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the clinical history of the SLE patients (i.e. recurrent abortions and/or thromboembolic event) 
and the morphologic and functional damage which their sera induce on the 10.5 days rat 
embryos and yolk sac in culture. We used as culture media sera from SLE /APLs patients 
during remission (The APLs patients were at least one year free of clotting events and the SLE 
patients had SLEDAI (Systemic lupus erythematosus disease activity index-a commulative 
clinical and laboratory index with higher scores representing increased disease activity) 2000 
less than 4 and compared it to control human sera. The survival of the embryos cultured in 
sera of SLE /APLs women decreased significantly from 87.5% to 70.9% in comparison to 
embryos cultured in control sera. There was a positive correlation between survival rate, the 
neurological developmental stage (calculated by summing the score given for the caudal 
neural tube, hind, mid and forebrain) and number of somites. Additionally a significant 
positive correlation between the growth parameters was demonstrated among the embryos 
cultured in sera from patients and controls: the larger embryos had larger yolk sacs; had 
higher general and neurologic developmental score and more somites, implying more mature 
embryos. (Ergaz et al., 2010). A high rate of anomalies in embryos cultured in sera from 
women with recurrent spontaneous abortions (Abir et al., 1994) or following the addition to 
the culture medium of purified IgG from SLE and APLs patients (Abir & Ornoy, 1996), 
differed from the study using sera obtained from non-pregnant patients in remission, where 
there was no increase in the rate of anomalies compared to controls. It can be speculated 
therefore, that the teratogenicity of the sera reflected the patient’s high-activity disease state 
(Clowse et al., 2005). Delayed neurological system development when the brain structures 
development were behind the other embryonic systems was the predominant finding in 
correlation with clinical studies published in the medical literature that reported learning and 
memory impairment among offspring of mothers with SLE (Urowitz et al., 2008, Ross et al., 
2003) and the finding that the main anomalies in our previous studies were neural tube defects 
(Abir et al., 1994). We speculate that the low activity of the disease allowed high survival and 
low anomalies rate in most of the sera but some sera remained teratogenic due to factors that 
were still active despite remission. We defined two sera groups: “toxic” sera with over-all 
survival rate under ⅔ and those cultured in “non-toxic” sera with over-all survival above ⅔. In 
order to define the characteristics of the “toxic” sera we analyzed the correlations between the 
survival rate, the growth parameters, maternal laboratory findings regarding APLs and the 
clinical history of the patients. We did not find a correlation between sera toxicity and: the 
diagnosis of APLs; The levels of the specific antibodies (anti-double stranded DNA, anti-single 
stranded DNA and the antiphospholipid antibodies: anti cardiolipin, anti-β2 glycoprotein, 
antiphosphatidylserine, antiphosphatidylcholine and antiphosphatidylethanolamine) which 
were high compared to human controls. There was no significant correlation between the 
survival rate and any specific antibody measured in those sera, the history of recurrent 
abortions and toxemia and the history of thrombo-embolic attacks. The yolk sac function was 
evaluated by measuring the 14C sucrose endocytic index which did not differ between the 
controls and SLE/APLs non toxic sera, this is explained by the fact that we studied the index 
only in “non toxic” sera.  
To evaluate the antioxidant defense mechanisms which include a variety of intracellular 
enzymes we evaluated superoxide dismutase, catalase like activity, and low molecular 
weight antioxidants. The low molecular weight antioxidants includes lypophilic and 
hydrophilic molecules like glutathione, carnosine, ascorbate (vitamin C), tocopherol 
(vitamin E), carotenoids (vitamin A), bilirubin, uric acid and flavonoids, which act directly 
with various reactive oxygen species, DNA repair enzymes and methionine sulphoxide 
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reductase that repair or remove reactive oxygen species-damaged biomolecules (Ornoy et 
al., 1999). Our previous studies on the reducing power of the low molecular weight 
antioxidants in control rat embryos and yolk sacs revealed only one peak 1 at 560-620 mvolts 
on 9.5-11.5 days of gestation and an additional peak (peak 2) at 950-970 mvolts first 
appearing on day 11.5 of gestation (Zaken et al., 2000), which is the day we ended our 
culture. The major components of peak 1 as measured by HPLC are ascorbic and uric acids, 
Tryptophan, carnosine, melatonine (Beit-Yannai et al., 1997) and thioacetic acid (Chevion et 
al., 2000) were found to be the major components of peak 2 in the rat brain . The low 
molecular weight antioxidants were evaluated by cyclic voltametry (Zaken et al., 2000). 
Most of the embryos cultured in the “toxic” SLE /APLs sera did not have the peak 2 of the 
low molecular weight antioxidants. The lack of the peak 2 in the present study may be the 
reflection of the delayed embryonic maturation as the embryos were smaller and less 
developed. This is similar to our finding of decreased low molecular weight antioxidants 
demonstrated by the absence of peak 2, in 10.5 days embryos cultured for 28 hours under 
diabetic conditions (Zaken et al., 2000). There was also a positive correlation between a 
lower peak 1 of low molecular weight antioxidants and recurrent abortions in the embryos 
cultured in the SLE /APLs sera that was not related to sera toxicity. Catalase and superoxide 
dismutase activity did not vary between the groups. It is unknown whether the oxidative 
insult has a similar effect on the different developing organs. We evaluated the oxidative 
stress in the total embryo, while the different organs and systems in the rat embryo may 
have different expressions under similar circumstances (Dubnov et al., 2000). The normal 
levels of the anti oxidant enzymes evaluated may indicate that sera toxicity is not related to 
oxidative stress.  We did not find any past clinical history or laboratory finding that was in 
correlation with the sera embryotoxicity. The possible causes for the high embryotoxicity of 
about half of the sera in remission are currently unknown. 
5.5 The effect of maternal medical treatment on sera teratogenicity  
The role of some treatment modalities was evaluated by rat embryo cultures in sera from 
women with and without medications. We examined 10.5 days old embryos cultured in sera 
from women suffering from SLE complicated by recurrent abortions, either untreated 
women, or treated with steroids and aspirin and compared the results to embryos cultured 
in sera from control women and to a pool of control rat sera. Untreated sera resulted in 
45.1% death rate compared to 29.8% in treated sera, 3.9% in control human and 5.1% in 
control rat serum. Malformation rate decreased from 73.3% in untreated sera to 37.5% in 
treated sera, 10.2% in human controls and 5.4% in rat controls. Malformations were mostly 
in the heart, brain, limbs and tail (Ornoy et al., 1998). Thus, treatment that improves 
pregnancy outcome also reduces the embryotoxic effects of the sera. 
5.6 The effect of maternal medical treatment on the extent of yolk sac damage 
Transmission electron microscopy of the yolk sacs revealed an increase in intracellular 
inclusions and decrease in microvilli number in both experimental groups, embryos 
cultured in sera from treated or untreated patients compared to controls. Scanning electron 
microscope revealed abnormally large entodermal cells, a decreased number of microvilli 
with sometimes crater formation (Ornoy et al., 1998). The anticoagulant treatment reduced 
fetal anomalies rate but did not improve yolk sac damage implying that yolk sac damage is 
only a component in the different factors leading to fetal damage. 
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5.7 The limitations of the early somite rat embryo culture system 
By using the early somite rat embryo culture system we evaluated the direct effect of sera 
from patients suffering from autoimmune diseases and analyzed the levels of the different 
sera variables during flare and remission. The impact of the different sera was not universal, 
and only some of the sera caused embryonic damage. Since the antiphospholipid antibodies 
were proven as the cause of embryotoxic effect only in some of the sera, we believe that 
other mechanisms are involved in the teratogenic effect and growth restriction as well. A 
disadvantage of this in vitro testing are also the limited culture time and limited period of 
embryogenesis that is undertaken in the commonly used culture system which restricts the 
range of embryotoxicity that can be induced. It may, therefore, render the testing system 
unsuitable for teratogens that are likely to exert their major toxicological effect very early or 
late in gestation (Webster et al., 1997). Additionally we evaluated embryonic growth, 
structural anomalies and yolk sac function. Infants of mothers who suffer from SLE 
experience mainly intra-uterine growth retardation, which may be more prominent at the 
final pregnancy stages not in correlation with the pregnancy stage of early somite rat 
embryos. The lack of change in oxidative stress parameters may reflect the evaluation of the 
embryo as a whole. It is unknown whether the oxidative insult has a similar effect on the 
different developing organs. The different organs and systems in the rat embryo may have 
different expressions under similar circumstances as shown in another murine model 
(Dubnov et al., 2000). 
In conclusion: Early somite rat embryos cultured in sera from women who suffered from 
autoimmune diseases had lower survival rate, increase anomalies rate and delayed 
maturation as reflected by their lower morphological score and less developed anti-oxidant 
system. The damage was related to IgG antibodies only in some of the embryos. 
Morphologic yolk sac damage was constant and did not improve with maternal medical 
treatment. 
6. Placental explants studies 
6.1 The effect of SLE/APLs sera on placental explants  
At the early somite stage the yolk sac is the equivalent of the human chorioallantoic 
placenta.  The inhibition of yolk sac growth even without inhibition of embryonic growth, as 
well as ultrastructural damage to the yolk sac endothelial cells may indicate that the 
primary insult or at least a major insult in SLE /APLs and recurrent abortions may be 
damage to the placenta.  
We therefore examined the effects of sera from the patients on early human placental explants 
obtained from interruptions of normal 5.5 to 7.5 week-old pregnancies (because of 
psychosocial reasons), and compared to the effects of sera from healthy women and of a 
chemically defined medium. Placental explants cultured on sera from untreated non-pregnant 
women with SLE/APLs demonstrated a significant decrease in the trophoblastic cell 
proliferation rate compared with non-pregnant control women (Ornoy et al., 2003). Placental 
extracts cultured in SLE/APLs had a higher rate of apoptosis, and reduced βhCG secretion in 
correlation with antiphospholipid antibodies levels. The sera were analyzed for the presence 
and quantification of anti-double stranded DNA, anti-single stranded DNA and 
antiphospholipid antibodies (anti cardiolipin, anti-β2glycoprotein, antiphosphatidylserine, 
antiphosphatidylcholine and antiphosphatidylethanolamine) and Anti-Ro and anti-La. High 
levels of all the different antiphospholipid atibodies and both anti-dsDNA and anti-ssDNA  
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(1) More specific, embryotoxic in 2/3 of the sera. 
(2) Less specific but allows to investigate the multi factorial mechanisms of embryotoxicity. 
(3) Evaluate blastocystic development. 
(4) Evaluate: Embryonic survival, score, anomalies rate and yolk sac apoptosis. 
(5) Evaluate trophoblastic cell proliferation, apoptosis and βhCG secretion. 
Fig. 3. In vitro cultures as an aid in clinical decisions making for recurrent abortions 
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showed a trend towards reduction in βhCG secretion by the placental extracts in culture. Titers 
of anti-Ro and anti-La did not correlate with a reduction in the βhCG levels, probably because 
anti-Ro and anti-La antibodies exert their effect on pregnancy by a passively transferred 
autoimmune disease in fetuses or newborns, causing neonatal lupus and not through placental 
damage. There was no specific single antibody that could be identified to cause the placental 
damage, but rather a combination of different antibodies was responsible for the cumulative 
damage, in accordance with the inconsistent findings of the effects of the different 
antiphospholipid antibodies (Schwartz et al., 2007). 
6.2 The effect of maternal medical treatment on the degree of damage induced in 
placental explants 
When we evaluated the impact of maternal treatment with steroids and/or aspirin on 
placental explants, treatment significantly increased proliferation rate compared with the 
untreated group but remained significantly lower than that found in the control non-
pregnant women. Additionally, a significant increase in the rate of the trophoblastic cell 
apoptosis was demonstrated compared to explants cultured in sera from treated or control 
women. The apoptotic rate, however, was still significantly higher in the treated group than 
that found in the control human group (Yacobi et al., 2002). 
6.3 The limitations of the placental explants culture system 
The placental explants system allows the investigation of the direct effect of sera on 
trophoblastic proliferation. This system where only young human placental explants are 
cultured does not seem to enable the investigation of late pregnancy damage induced by the 
various mechanisms. Additionally it does not allow the investigation of growth parameters 
which tend to impact the fetus at later pregnancy stages. 
In conclusion: Placental explants culture in SLE/APLs sera had decreased trophoblastic 
cells proliferation, a higher rate of apoptosis, and reduced βhCG secretion in correlation 
with antiphospholipid antibodies levels, and increased yolk sac trophoblastic cell apoptosis.  
7. Conclusions 
The pathophysiology of fetal loss and growth restriction among patients suffering from 
SLE/APLs is still an open question that needs to be studied. The pre-implantation murine 
and early somite rat embryo culture offers a model for evaluation of the direct effect of the 
different antibodies and molecules on survival and growth at different time points during 
pregnancy. The concomitant evaluation of the yolk sac function allows the investigation of 
those molecules on the rodent’s placental equivalent. The addition of the human early 
placental extracts culture improves the understanding of the disturbance to early placental 
differentiation, migration and hormone production induced by similar teratogens. 
8. Future research possibilities  
New molecules associated with fetal death, embryotoxicity and growth failure were 
discovered in the last years. The direct effect of those molecules can be evaluated in vitro on 
placental explants, murine pre-implantation embryos and on early somite rat embryos in 
culture in order to isolate the impact that each molecule has, solely or in combination with 
other molecules on pregnancy outcome. The evaluation of the pathological, immunological 
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and biochemical parameters of the cultured embryos may add more clues to the multi-
factorial mechanism of fetal damage among women suffering from autoimmune diseases. 
The understanding of those mechanisms may help to develop new treatment modalities 
which can also be evaluated in this model. 
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